Bronkaid LS-SYP
COMPOSITION : Ambroxol 30 mg + Guaiphenesin 50 mg + Levosalbutamol 1 mg
Categories: General, Respiratory, Respiratory, Therapeutic
Description
Product Description
BRONKAID-LS Syrup is a combination respiratory formulation containing Ambroxol Hydrochloride, Guaiphenesin and Levosalbutamol. The combination brings together mucolytic, expectorant and bronchodilator actions and is formulated as an oral syrup.
It is supplied in a 100 mL bottle.
Therapeutic Information
Therapeutic Category
Respiratory / Cough & Expectorant
Drug Classes
| Ingredient | Pharmacological role |
|---|---|
| Ambroxol Hydrochloride | Mucolytic |
| Guaiphenesin | Expectorant |
| Levosalbutamol | β₂-adrenergic bronchodilator |
General therapeutic role
- Ambroxol helps reduce the viscosity of respiratory mucus.
- Guaiphenesin promotes the clearance of respiratory secretions.
- Levosalbutamol produces bronchodilation by stimulating β₂-adrenergic receptors.
This makes the combination relevant to productive cough associated with bronchospasm/airway obstruction, when clinically appropriate.
Additional information
| Composition |
Ambroxol Hydrochloride 30 mg + Guaiphenesin 50 mg + Levosalbutamol 1 mg |
|---|---|
| Dosage Form |
Syrup |
| Pack size |
100 mL |
| Therapeutic Segment |
Respiratory |
| Route |
Oral |
| Therapeutic Category |
Cough & Expectorant |
| MRP |
₹120/- |
| Origin |
India |
Related products
CEFXUM 500
Composition: Cefuroxime axetil 500 mg
SULTAMIK 375
Composition: Sultamicillin Tosilate B.P. 375 mg, eq. to Sulbactam 147 mg and Ampicillin 220 mg
CLARITEX-250
Composition: Clarithromycin I.P. 250 mg
NUVIGIL -MN SR
Composition: Methylcobalamin 1500mcg + Pregabalin 75mg + Nortriptyline 10mg
APIXAN 5
Composition: Apixaban 5 mg
SATIN -F
Composition: Atorvastatin 10 mg + Fenofibrate 160 mg
SATIN 40
Composition: Atorvastatin Calcium I.P. eq. to Atorvastatin 40 mg
